S. Saravanan

发表

Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations.

D. Katzenstein, R. Kantor, Davey M. Smith, 2012, Journal of acquired immune deficiency syndromes.

HIV-1 reverse transcriptase nucleotide substitutions in subtype C-infected, drug-naive, and treatment-experienced patients in South India.

Davey M. Smith, G. Waldrop, K. Mayer, 2011, Journal of acquired immune deficiency syndromes.

High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy

R. Kantor, S. Solomon, S. Cu-Uvin, 2018, The Journal of antimicrobial chemotherapy.

Pooled nucleic acid testing strategy for monitoring HIV-1 treatment in resource limited settings.

Davey M. Smith, S. Solomon, N. Kumarasamy, 2019 .

Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India

S. Ray, D. Celentano, S. Solomon, 2010, The Indian journal of medical research.

Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients

S. Solomon, S. Solomon, S. Poongulali, 2018, The Indian journal of medical research.

Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients

S. Solomon, S. Solomon, S. Poongulali, 2016, Indian journal of pharmacology.

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

O. Laeyendecker, T. Quinn, D. Celentano, 2020, Journal of hepatology.

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa

C. Gray, C. Williamson, U. Ranga, 2017, BMC Infectious Diseases.

The evolution of regulatory elements in the emerging promoter variant strains of HIV-1

R. Paranjape, U. Ranga, S. Solomon, 2021, bioRxiv.

Occult Hepatitis B Virus Infection in a Cohort of Liver Disease Patients with Chronic Hepatitis C: A significant Association of HCV Genotype 1b in South India

G. Waldrop, S. Solomon, S. Thyagarajan, 2013 .

Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.

S. Thyagarajan, S. Solomon, N. Kumarasamy, 2009, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Prevalence and Phylogenetic Characterization of Hepatitis C Virus Among Indian Men Who Have Sex With Men: Limited Evidence for Sexual Transmission

D. Celentano, P. Duggal, S. Solomon, 2020 .

Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission.

D. Celentano, P. Duggal, S. Solomon, 2020, The Journal of infectious diseases.

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

O. Laeyendecker, T. Quinn, D. Celentano, 2015, The Lancet. Infectious diseases.

Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India

A. Giuliano, Hui-Yi Lin, M. Tommasino, 2016, International journal of STD & AIDS.

HIV-1 drug resistance among newly HIV-1 infected individuals attending tertiary referral center in Chennai, India.

S. Solomon, S. Solomon, N. Kumarasamy, 2011, Indian journal of medical sciences.

Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?

E. Shankar, S. Solomon, N. Kumarasamy, 2008, Journal of Inflammation.

Detection of pulmonary Mycoplasma pneumoniae infections in HIV-infected subjects using culture and serology.

E. Shankar, S. Solomon, N. Kumarasamy, 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Epidemiological studies on pulmonary pathogens in HIV-positive and -negative subjects with or without community-acquired pneumonia with special emphasis on Mycoplasma pneumoniae.

E. Shankar, S. Solomon, S. Solomon, 2007, Japanese journal of infectious diseases.

Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells

S. Solomon, N. Kumarasamy, S. Pallikkuth, 2018, PloS one.

Immune correlates of cardiovascular co-morbidity in HIV infected participants from South India

S. Solomon, N. Kumarasamy, S. Pallikkuth, 2022, BMC immunology.

Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.

D. Katzenstein, R. Kantor, K. Mayer, 2009, Journal of virological methods.

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

J. Gallant, Myron S. Cohen, K. Mayer, 2016, Journal of acquired immune deficiency syndromes.

Current Status of Point‐of‐Care Testing for Human Immunodeficiency Virus Drug Resistance

James J. Lai, Ingrid A. Beck, R. Kantor, 2017, The Journal of infectious diseases.

Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India

T. Quinn, S. Ray, P. Duggal, 2021, Hepatology.

Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 Subtypes

D. Katzenstein, J. Hogan, S. Istrail, 2015, Open forum infectious diseases.

Deep learning and social network analysis elucidate drivers of HIV transmission in a high-incidence cohort of people who inject drugs

C. Latkin, P. Duggal, S. Solomon, 2022, Science advances.

The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India.

E. Shankar, S. Solomon, S. Thyagarajan, 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Comparison of HBV-active HAART regimens in an HIV–HBV multinational cohort: outcomes through 144 weeks

S. Kulkarni, C. Thio, U. Lalloo, 2015, AIDS.

Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women

S. Swaminathan, L. Hanna, S. Poongulali, 2021, Microbiology spectrum.

Deciphering the role of mucosal immune responses and cervicovaginal microbiome in resistance to HIV infection in HIV-exposed seronegative (HESN) women

S. Swaminathan, L. Hanna, S. Poongulali, 2021, bioRxiv.

Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.

Oliver Laeyendecker, Shanmugam Saravanan, David D Celentano, 2016, The lancet. HIV.

Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

S. Thyagarajan, N. Kumarasamy, P. Balakrishnan, 2007, World journal of gastroenterology.

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India

M. Suresh Kumar, David L. Thomas, D. Thomas, 2016, PloS one.

Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines.

E. Shankar, S. Thyagarajan, P. Kulkarni, 2008, World journal of gastroenterology.

Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers.

E. Shankar, S. Thyagarajan, S. Nandakumar, 2008, Japanese journal of infectious diseases.

Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

M. Ekstrand, N. Kumarasamy, E. Heylen, 2011, International health.

HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India.

Davey M. Smith, S. Solomon, K. Murugavel, 2017, AIDS research and human retroviruses.

Occult HBV infection in HIV‐infected adults and evaluation of pooled NAT for HBV

D. Smith, S. Solomon, K. Murugavel, 2018, Journal of viral hepatitis.

High Prevalence of Hepatitis Delta Virus among Patients with Chronic Hepatitis B Virus Infection and HIV-1 in an Intermediate Hepatitis B Virus Endemic Region

Davey M. Smith, G. Waldrop, K. Mayer, 2014, Journal of the International Association of Providers of AIDS Care.

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration

Huldrych F. Günthard, Dominique Goedhals, Susan P. Holmes, 2017, EBioMedicine.

High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.

R. Schooley, R. Kantor, K. Mayer, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seroprevalence of hepatitis delta virus infection among subjects with underlying hepatic diseases in Chennai, southern India.

E. Shankar, S. Thyagarajan, S. Solomon, 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India

M. Rodgers, S. Solomon, G. Lucas, 2020, Scientific Reports.

Anti-HIV microRNA expression in a novel Indian cohort

V. Scaria, S. Brahmachari, B. Pillai, 2016, Scientific Reports.

Correlates of HIV and malaria co-infection in Southern India

S. Letendre, Davey M. Smith, N. Kumarasamy, 2012, Malaria Journal.

The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

U. Ranga, S. Solomon, V. Prasad, 2016, AIDS research and human retroviruses.

Multiple NF-κB Sites in HIV-1 Subtype C Long Terminal Repeat Confer Superior Magnitude of Transcription and Thereby the Enhanced Viral Predominance*

A. Mahadevan, S. Shankar, K. Jeang, 2012, The Journal of Biological Chemistry.

PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C

R. Satya, I. Hewlett, U. Ranga, 2018, The Journal of Biological Chemistry.

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India

G. Waldrop, S. Solomon, R. Vignesh, 2018, Current HIV research.

Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India

D. Boon, S. Ray, D. Persaud, 2019, VirusDisease.

Performance of cepheid GeneXpert HIV-1 viral load plasma assay to accurately detect treatment failure: a clinical meta-analysis.

Youyi Fong, Jilian A Sacks, Mercedes Perez Gonzalez, 2019, AIDS.

Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India.

R. Schooley, R. Kantor, Davey M. Smith, 2013, AIDS research and human retroviruses.

Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm

J. Mellors, M. Weinberger, W. Miller, 2016, BMC Infectious Diseases.

Genotypic HIV-1 Drug Resistance Among Patients Failing Tenofovir-Based First-Line HAART in South India.

S. Solomon, S. Solomon, S. Poongulali, 2016, AIDS research and human retroviruses.

Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India

D. Katzenstein, R. Kantor, K. Mayer, 2009, Antiviral therapy.

Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.

D. Katzenstein, R. Kantor, K. Mayer, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India.

S. Solomon, S. Solomon, S. Poongulali, 2016, AIDS research and human retroviruses.

The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India.

R. Kantor, Davey M. Smith, K. Mayer, 2011, Journal of acquired immune deficiency syndromes.

1 Multiple F-κB sites in HIV-1 subtype C LTR confer superior magnitude of transcription and thereby the enhanced viral predominance

A. Mahadevan, S. Shankar, K. Jeang, 2012 .

The Evolution of Regulatory Elements in the Emerging Promoter-Variant Strains of HIV-1 Subtype C

R. Paranjape, U. Ranga, S. Solomon, 2021, Frontiers in Microbiology.

Elevated Numbers of HIV-Specific Poly-Functional CD8+ T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals

S. Swaminathan, L. Hanna, S. Poongulali, 2021, Frontiers in Immunology.

Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India.

J. Bhattacharya, S. Solomon, Rajat Goyal, 2018, The Journal of general virology.

Cold Agglutinins in HIV-Seropositive Participants and Diagnosis of Respiratory Disease Due to Mycoplasma pneumoniae

S. Solomon, R. Vignesh, P. Balakrishnan, 2009, Journal of the International Association of Physicians in AIDS Care.

Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay.

G. Waldrop, K. Mayer, S. Solomon, 2012, Journal of virological methods.

Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations.

R. Schooley, R. Kantor, Davey M. Smith, 2012, AIDS research and human retroviruses.

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

J. Gallant, J. Eron, M. Hosseinipour, 2017, Journal of acquired immune deficiency syndromes.

Cost-effective HIV-1 virological monitoring in resource-limited settings using a modified commercially available qPCR RNA assay.

A. Torti, S. Solomon, P. Balakrishnan, 2017, Journal of virological methods.

Drug susceptibility and resistance mutations after first-line failure in resource limited settings.

D. Katzenstein, J. Bartlett, W. Stevens, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

B. Gazzard, R. Kaiser, B. Larder, 2021, The Journal of antimicrobial chemotherapy.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings

Dechao Wang, Shanmugam Saravanan, John Baxter, 2018, The Journal of antimicrobial chemotherapy.

Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.

J. Mellors, C. Wallis, C. Zeh, 2017, Journal of virological methods.

Performance of point‐of‐care Xpert HIV‐1 plasma viral load assay at a tertiary HIV care centre in Southern India

Shanmugam Saravanan, S. Solomon, R. Vignesh, 2017, Journal of medical microbiology.

Etravirine and Rilpivirine Drug Resistance Among HIV-1 Subtype C Infected Children Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in South India.

R. Kantor, Davey M. Smith, S. Mothi, 2016, AIDS research and human retroviruses.

Association of circulatory Tfh-like cells with neutralizing antibody responses among chronic HIV-1 subtype C infected long-term nonprogressors and progressors.

S. Solomon, Rajat Goyal, L. Hanna, 2019, Pathogens and disease.

Evaluation of dried blood spot as an alternative specimen for the diagnosis of anti-HCV in resource-limited settings.

S. Mehta, S. Solomon, P. Balakrishnan, 2014, Indian Journal of Medical Microbiology.

Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings.

M. Hughes, R. Gross, J. Mellors, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Diverse Human Immunodeficiency Virus–1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings

R. Gross, J. Ritz, B. Grinsztejn, 2020 .

Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

M. Ekstrand, N. Kumarasamy, E. Heylen, 2011, International health.

Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.

S. Thyagarajan, S. Solomon, N. Kumarasamy, 2009, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Temporal change in population-level prevalence of detectable HIV viraemia and its association with HIV incidence in key populations in India: a serial cross-sectional study.

O. Laeyendecker, D. Celentano, Eshan U. Patel, 2021, The lancet. HIV.